Omni Bio Pharmaceutical Inc (OTC BB: OMBP)
, a biotech & pharma stock, is featured as today’s top momentum gainer
since it gained over 9% during the last two consecutive trading days with
increased volumes. OMBP was among the top gainers in the U.S. healthcare
space after rising 18.4% during its last trading session and closed at
$0.45 while recording huge volumes of over 107,650 shares. During the last
5-trading sessions, OMBP gained 63.6% with daily average traded volumes
of 68,396 shares, while the stock accumulated over 15% during the past
one month with average volumes of 20,614 shares.
Company Description:
Omni Bio Pharmaceutical Inc (OTC BB: OMBP) owns the licenses to issued
and pending patents from the University of Colorado. The company develops
therapeutics for bacterial and viral diseases; biohazards; diabetes; and
transplant rejection.
1-Year Stock Chart:
Source: Bloomberg
